Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Yong An

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8010-8035; OpenAlex author ID A5051862342. Sources: OpenAlex.

Their work

Papers
16 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 5 papers · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 4 papers · 2019: none · 2020: 1 paper

Papers 16

  1. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 vi… Co-author DOI 10.1080/15384047.2019.1702401↗
  2. Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis. Co-author DOI 10.1111/cas.13733↗
  3. circZMYM2 Competed Endogenously with miR-335-5p to Regulate JMJD2C in Pancreatic Cancer. Co-author DOI 10.1159/000495868↗
  4. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer. Co-author DOI 10.1186/s12935-018-0643-7↗
  5. MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS. Last author DOI 10.5114/aoms.2018.72564↗
  6. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Co-author DOI 10.18632/oncotarget.16462↗
  7. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2. First author DOI 10.18632/oncotarget.13490↗
  8. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Co-author DOI 10.3892/ijo.2013.2189↗
  9. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells. First author DOI 10.3892/or.2013.2881↗
  10. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.27715↗
  11. MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. Co-author DOI 10.1016/j.canlet.2012.11.005↗
  12. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Co-author DOI 10.3892/ijo.2013.2015↗
  13. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Co-author DOI 10.3892/mmr.2013.1504↗
  14. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. First author DOI 10.3892/or.2013.2297↗
  15. High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreat… Co-author DOI 10.1002/ijc.26290↗
  16. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an i… Co-author DOI 10.1097/mpa.0b013e318217945e↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huihua Cai · 6 shared papers, 2016–2018 · strength 0.46
  2. Xuemin Chen · 5 shared papers, 2016–2018 · strength 0.38
  3. Li Xu · 3 shared papers, 2013–2020 · strength 0.20
  4. Jishu Wei · 6 shared papers, 2011–2013 · strength 0.18
  5. Xinquan Wu · 2 shared papers, 2018 · strength 0.16
  6. Yong Yang · 2 shared papers, 2017–2018 · strength 0.16
  7. Kuirong Jiang · 5 shared papers, 2011–2013 · strength 0.15
  8. Yong Jiang · 2 shared papers, 2017–2018 · strength 0.15
  9. Xiaofeng Xue · 5 shared papers, 2011–2013 · strength 0.15
  10. Dong Xu · 2 shared papers, 2014–2020 · strength 0.14
  11. Xiaozhou He · 2 shared papers, 2016–2017 · strength 0.12
  12. Jie J. Yao · 3 shared papers, 2011–2017 · strength 0.12
  13. Yi Miao · 4 shared papers, 2011–2013 · strength 0.12
  14. Dong Tang · 4 shared papers, 2011–2013 · strength 0.11
  15. Yi Miao · 3 shared papers, 2013–2014 · strength 0.11
  16. Min Tu · 3 shared papers, 2013 · strength 0.10
  17. Qingguang Wang · 2 shared papers, 2013–2014 · strength 0.09
  18. Xiaozhou He · 1 shared paper, 2018 · strength 0.09
  19. Qiang Li · 3 shared papers, 2011–2013 · strength 0.09
  20. Wentao Gao · 3 shared papers, 2011–2013 · strength 0.09
  21. Junli Wu · 3 shared papers, 2011–2013 · strength 0.09
  22. Zipeng Lu · 3 shared papers, 2011–2013 · strength 0.08
  23. Baoqiang Wu · 1 shared paper, 2018 · strength 0.08
  24. Xuemin Chen · 1 shared paper, 2018 · strength 0.08
  25. Yue Zhang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.